TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
10.70
-0.50 (-4.46%)
At close: Sep 12, 2025, 4:00 PM EDT
10.82
+0.12 (1.12%)
After-hours: Sep 12, 2025, 7:59 PM EDT

TransCode Therapeutics Stock Forecast

RNAZ's stock price has decreased by -95.54% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for TransCode Therapeutics stock has a target of 280, which predicts a 2,516.82% increase from the current stock price of 10.7.

Price Target: $280 (+2,516.82%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$280$280$280$280
Change+2516.8%+2516.8%+2516.8%+2516.8%
* Price targets were last updated on Apr 16, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for TransCode Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$560$280
Strong BuyMaintains$560$280+2,516.82%Apr 16, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$560
Strong BuyReiterates$560+5,133.64%Mar 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$560
Strong BuyReiterates$560+5,133.64%Feb 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$560
Strong BuyReiterates$560+5,133.64%Feb 6, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$84$560
Strong BuyMaintains$84$560+5,133.64%Dec 18, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
510.00K
EPS This Year
-4.46
from -1.32K
EPS Next Year
-0.33
from -4.46
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------510.00K
Revenue Growth
-------
EPS
-----1,317.42-4.46-0.33
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/a525,000
Avgn/a510,000
Lown/a490,000

Revenue Growth

Revenue Growth202520262027
High--
Avg--
Low--

EPS Forecast

EPS202520262027
High-4.59-0.34
Avg-4.46-0.33
Low-4.28-0.31

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.